Collegium Pharmaceutical, Inc. (COLL)

NASDAQ: COLL · IEX Real-Time Price · USD

32.36

+0.27 (0.84%)

At close: Jul 19, 2024, 4:00 PM

33.50

+1.14 (3.52%)

Pre-market: Jul 22, 2024, 8:24 AM EDT

Collegium Pharmaceutical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2013
Net Income	93.29	48.16	-25	71.52	26.75	-22.72	Upgrade
Depreciation & Amortization	149.46	149.26	138.94	68.92	61.61	1.04	Upgrade
Share-Based Compensation	28.58	27.14	22.87	24.26	21.91	16.53	Upgrade
Other Operating Activities	37.68	50.2	-12.58	-61.13	-16.33	32.93	Upgrade
Operating Cash Flow	309.02	274.75	124.23	103.56	93.94	27.78	Upgrade
Operating Cash Flow Growth	74.37%	121.16%	19.96%	10.24%	238.13%	-83.60%	Upgrade
Capital Expenditures	-0.85	-0.46	-1.62	-1.94	-373.77	-6.44	Upgrade
Acquisitions	0	0	-572.07	0	0	0	Upgrade
Change in Investments	-87.91	-70.35	0	0	0	0	Upgrade
Investing Cash Flow	-88.76	-70.81	-573.69	-1.94	-373.77	-6.44	Upgrade
Share Issuance / Repurchase	-65.82	-66.36	-2.25	-35.91	6.58	2.05	Upgrade
Debt Issued / Paid	-183.77	-65.92	442.68	-50	281.39	0	Upgrade
Other Financing Activities	-13.04	-7.9	-3.71	-3.39	-1.5	-0.01	Upgrade
Financing Cash Flow	-262.62	-140.18	436.72	-89.3	286.47	2.04	Upgrade
Net Cash Flow	-42.37	63.76	-12.74	12.31	6.64	23.39	Upgrade
Free Cash Flow	308.16	274.29	122.61	101.61	-279.83	21.35	Upgrade
Free Cash Flow Growth	75.56%	123.71%	20.66%	-	-	-85.28%	Upgrade
Free Cash Flow Margin	54.36%	48.40%	26.43%	36.70%	-90.26%	7.19%	Upgrade
Free Cash Flow Per Share	9.53	8.13	3.62	2.91	-8.13	0.64	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).